Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
13 March 2017
Answer given by Mr Andriukaitis on behalf of the Commission

The Commission is holding regular review missions in Greece and, within the boundaries of its competences, intends to continue to raise concerns related to public health. According to the Greek health authorities, efforts are being made to provide the necessary drugs to those hospitals which provide medication to vulnerable groups.

As stated in the Commission's reply to E-001016/2016, the EU is providing financial support to health-related actions proposed by Greece according to its national priorities through the European Structural and Investment Funds. In addition, the Structural Reform Support Services is helping with facilitating expertise in collaboration with the World Health Organisation.

As the Commission pointed out in its answer to the Written Question E-009252/2016 raised by the Honourable Member, the Commission has limited competence to deal with specific situations in the Member States as regards health policy, healthcare and the organisation of health services.

Last updated: 15 March 2017Legal notice